CD47 and neoplasm: Binding to CD47, the SIRPα-Fc fusion protein can block the immunosuppressive CD47–SIRPα signal between macrophages and tumor cells as a decoy receptor and has demonstrated its immunotherapeutic efficacy in various tumors [1].